Sign in →

Test Code OPRM1 Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy

Reporting Name

OPRM1 Genotype, Naltrexone Efficacy

Useful For

Identifying individuals with a higher probability of successful treatment for alcoholism with naltrexone

Performing Laboratory

Mayo Medical Laboratories in Rochester

Specimen Type

Whole Blood EDTA


Specimen Required


Multiple whole blood EDTA genotype tests can be performed on a single specimen after a single extraction. See Multiple Whole Blood EDTA Genotype Tests in Special Instructions for a list of tests that can be ordered together.

 

Container/Tube: Lavender top (EDTA)

Specimen Volume: 3 mL

Collection Instructions: Send specimen in original tube.

Forms: New York Clients-Informed consent is required. Please document on request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions.


Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time
Whole Blood EDTA Ambient (preferred)
  Refrigerated 

Reference Values

An interpretive report will be provided.

Day(s) and Time(s) Performed

Tuesday; 8 a.m.

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

81479-Unlisted molecular pathology procedure

LOINC Code Information

Test ID Test Order Name Order LOINC Value
OPRM1 OPRM1 Genotype, Naltrexone Efficacy In Process

 

Result ID Test Result Name Result LOINC Value
31912 OPRM1 Result In Process
31913 OPRM1 Interpretation 69047-9
31914 OPRM1 Reviewed by No LOINC Needed

Method Name

Polymerase Chain Reaction (PCR) 5'-Nuclease End point Allelic Discrimination Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular System, Inc.)